Clinical trial NCT00879489 - References

Breast Cancer — Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer

Citation(s)

•   Barsoum AL, Coggin JH Jr
  Immunogenicity of a soluble partially purified oncofetal antigen from murine fibrosarcoma in syngeneic mice. J Biol Response Mod. 1989 Dec;8(6):579-92.
•   Barsoum AL, Coggin JH Jr
  Isolation and partial characterization of a soluble oncofetal antigen from murine and human amniotic fluids. Int J Cancer. 1991 May 10;48(2):248-52.
•   Coggin JH Jr, Barsoum AL, Rohrer JW
  37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers. Anticancer Res. 1999 Nov-Dec;19(6C):5535-42.
•   Coggin JH Jr, Barsoum AL, Rohrer JW
  Tumors express both unique TSTA and crossprotective 44 kDa oncofetal antigen. Immunol Today. 1998 Sep;19(9):405-8. Review.
•   Coggin JH Jr, Rohrer JW, Barsoum AL
  True immunogenicity of oncofetal antigen/immature laminin receptor protein. Cancer Res. 2004 Jul 1;64(13):4685; author reply 4685.
•   Coggin JH Jr, Rohrer SD, Hester RD, Barsoum AL, Rashid HU, Gussack GS
  44-kd oncofetal transplantation antigen in rodent and human fetal cells. Implications of recrudescence in human and rodent cancers. Arch Otolaryngol Head Neck Surg. 1993 Nov;119(11):1257-66.
•   Coggin JH Jr
  Classification of tumor-associated antigens in rodents and humans. Immunol Today. 1994 May;15(5):246-7.
•   Coggin JH Jr
  Embryonic antigens in malignancy and pregnancy: common denominators in immune regulation. Ciba Found Symp. 1983;96:28-54. Review.
•   Coggin JH Jr
  Oncofetal antigens. Nature. 1986 Jan 30-Feb 5;319(6052):428.
•   Gussack GS, Rohrer SD, Hester RB, Liu PI, Coggin JH Jr
  Human squamous cell carcinoma lines express oncofetal 44-kD polypeptide defined by monoclonal antibody to mouse fetus. Cancer. 1988 Jul 15;62(2):283-90.
•   Höltl L, Zelle-Rieser C, Gander H, Papesh C, Ramoner R, Bartsch G, Rogatsch H, Barsoum AL, Coggin JH Jr, Thurnher M
  Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin Cancer Res. 2002 Nov;8(11):3369-76.
•   Payne WJ Jr, Coggin JH Jr
  Mouse monoclonal antibody to embryonic antigen: development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization. J Natl Cancer Inst. 1985 Sep;75(3):527-44.
•   Rohrer JW, Barsoum AL, Coggin JH Jr
  Identification of oncofetal antigen/immature laminin receptor protein epitopes that activate BALB/c mouse OFA/iLRP-specific effector and regulatory T cell clones. J Immunol. 2006 Mar 1;176(5):2844-56.
•   Rohrer JW, Barsoum AL, Dyess DL, Tucker JA, Coggin JH Jr
  Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes. J Immunol. 1999 Jun 1;162(11):6880-92.
•   Rohrer JW, Coggin JH Jr
  CD8 T cell clones inhibit antitumor T cell function by secreting IL-10. J Immunol. 1995 Dec 15;155(12):5719-27.
•   Rohrer JW, Culpepper C, Barsoum AL, Coggin JH Jr
  Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning. J Immunol. 1995 Mar 1;154(5):2266-80.
•   Zelle-Rieser C, Barsoum AL, Sallusto F, Ramoner R, Rohrer JW, Höltl L, Bartsch G, Coggin JH JR, Thurnher M
  Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma. J Urol. 2001 May;165(5):1705-9.

Phase I/II Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer

Details for clinical trial NCT00879489